Australia · Delayed Price · Currency is AUD Resonance Health Company Description
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa.
It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFatSmart, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFatSmart into a consolidated report; and CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading.
It also provides phantoms comprising FerriScan, T1CMR, and T2CMR phantoms for the calibration of MRI machines.
In addition, the company operates as an imaging contract research organization that provides comprehensive proposal and project management support, site set-up, imaging charter development, clinical reports, data transfer agreements, and compliance services for clinical trial sponsors.
It serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for clinical trials.
Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.
| Country | Australia |
| Founded | 1987 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Andrew Harrison |
Contact Details
Address: 141 Burswood Road Burswood, Washington 6100 Australia | |
| Phone | 61 8 9286 5300 |
| Website | resonancehealth.com |
Stock Details
| Ticker Symbol | RHT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000RHT2 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Andrew Duncan Harrison BCom (Hons), MAICD | Chief Executive Officer and Director |
| Benjamin Carruthers | Chief Financial Officer |
| Mitchell M. Wells B.Com., B.Comm, L.L.B. | Company Secretary and Non Executive Director |
| Gavin Pinto | Chief Technology Officer |
| Narelle Mounsey | General Manager of People and Culture |
| Dr. Wenjie Pang Ph.D. | Chief Scientific Officer ? Imaging and AI |
| Dr. Sherif Boulos Ph.D. | Chief Scientific Officer of Molecular |